259 related articles for article (PubMed ID: 35993245)
21. Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension.
Wang Y; Dai S; Cheng X; Prado E; Yan L; Hu J; He Q; Lv Y; Lv Y; Du L
Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):639-651. PubMed ID: 30954415
[TBL] [Abstract][Full Text] [Related]
22. Silencing EIF3A ameliorates pulmonary arterial hypertension through HDAC1 and PTEN/PI3K/AKT pathway in vitro and in vivo.
Yang HT; Wang G; Zhu PC; Xiao ZY
Exp Cell Res; 2023 May; 426(1):113555. PubMed ID: 36921705
[TBL] [Abstract][Full Text] [Related]
23. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
[TBL] [Abstract][Full Text] [Related]
24. miR-223 reverses experimental pulmonary arterial hypertension.
Meloche J; Le Guen M; Potus F; Vinck J; Ranchoux B; Johnson I; Antigny F; Tremblay E; Breuils-Bonnet S; Perros F; Provencher S; Bonnet S
Am J Physiol Cell Physiol; 2015 Sep; 309(6):C363-72. PubMed ID: 26084306
[TBL] [Abstract][Full Text] [Related]
25. STARS knockout attenuates hypoxia-induced pulmonary arterial hypertension by suppressing pulmonary arterial smooth muscle cell proliferation.
Shi Z; Wu H; Luo J; Sun X
Biomed Pharmacother; 2017 Mar; 87():397-404. PubMed ID: 28068629
[TBL] [Abstract][Full Text] [Related]
26. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW
Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807
[TBL] [Abstract][Full Text] [Related]
27. Cathepsin S promotes the development of pulmonary arterial hypertension.
Chang CJ; Hsu HC; Ho WJ; Chang GJ; Pang JS; Chen WJ; Huang CC; Lai YJ
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L1-L13. PubMed ID: 31017016
[TBL] [Abstract][Full Text] [Related]
28. Upregulated expression of STIM2, TRPC6, and Orai2 contributes to the transition of pulmonary arterial smooth muscle cells from a contractile to proliferative phenotype.
Fernandez RA; Wan J; Song S; Smith KA; Gu Y; Tauseef M; Tang H; Makino A; Mehta D; Yuan JX
Am J Physiol Cell Physiol; 2015 Apr; 308(8):C581-93. PubMed ID: 25673771
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic Dysregulation of the Dynamin-Related Protein 1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications.
Chen KH; Dasgupta A; Lin J; Potus F; Bonnet S; Iremonger J; Fu J; Mewburn J; Wu D; Dunham-Snary K; Theilmann AL; Jing ZC; Hindmarch C; Ormiston ML; Lawrie A; Archer SL
Circulation; 2018 Jul; 138(3):287-304. PubMed ID: 29431643
[TBL] [Abstract][Full Text] [Related]
30. Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension.
Masson B; Le Ribeuz H; Sabourin J; Laubry L; Woodhouse E; Foster R; Ruchon Y; Dutheil M; Boët A; Ghigna MR; De Montpreville VT; Mercier O; Beech DJ; Benitah JP; Bailey MA; Humbert M; Montani D; Capuano V; Antigny F
Circ Res; 2022 Oct; 131(9):e102-e119. PubMed ID: 36164973
[TBL] [Abstract][Full Text] [Related]
31. Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.
Yamamura A; Guo Q; Yamamura H; Zimnicka AM; Pohl NM; Smith KA; Fernandez RA; Zeifman A; Makino A; Dong H; Yuan JX
Circ Res; 2012 Aug; 111(4):469-81. PubMed ID: 22730443
[TBL] [Abstract][Full Text] [Related]
32. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W
Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
[TBL] [Abstract][Full Text] [Related]
33. Functional interaction between PDGFβ and GluN2B-containing NMDA receptors in smooth muscle cell proliferation and migration in pulmonary arterial hypertension.
Quatredeniers M; Nakhleh MK; Dumas SJ; Courboulin A; Vinhas MC; Antigny F; Phan C; Guignabert C; Bendifallah I; Vocelle M; Fadel E; Dorfmüller P; Humbert M; Cohen-Kaminsky S
Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L445-L455. PubMed ID: 30543306
[TBL] [Abstract][Full Text] [Related]
34. Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells.
Price LC; Shao D; Meng C; Perros F; Garfield BE; Zhu J; Montani D; Dorfmuller P; Humbert M; Adcock IM; Wort SJ
Respir Res; 2015 Sep; 16(1):114. PubMed ID: 26382031
[TBL] [Abstract][Full Text] [Related]
35. ALDH1A3 Coordinates Metabolism With Gene Regulation in Pulmonary Arterial Hypertension.
Li D; Shao NY; Moonen JR; Zhao Z; Shi M; Otsuki S; Wang L; Nguyen T; Yan E; Marciano DP; Contrepois K; Li CG; Wu JC; Snyder MP; Rabinovitch M
Circulation; 2021 May; 143(21):2074-2090. PubMed ID: 33764154
[TBL] [Abstract][Full Text] [Related]
36. RAS protein activator like 2 promotes the proliferation and migration of pulmonary artery smooth muscle cell through AKT/mammalian target of Rapamycin complex 1 pathway in pulmonary hypertension.
Hu S; Zhao Y; Qiu C; Li Y
Bioengineered; 2022 Feb; 13(2):3516-3526. PubMed ID: 35044284
[TBL] [Abstract][Full Text] [Related]
37. CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension.
Abid S; Marcos E; Parpaleix A; Amsellem V; Breau M; Houssaini A; Vienney N; Lefevre M; Derumeaux G; Evans S; Hubeau C; Delcroix M; Quarck R; Adnot S; Lipskaia L
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31320454
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension.
Zhou J; Li F; Yang Y
Respir Res; 2022 Aug; 23(1):223. PubMed ID: 36042446
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.
Hadri L; Kratlian RG; Benard L; Maron BA; Dorfmüller P; Ladage D; Guignabert C; Ishikawa K; Aguero J; Ibanez B; Turnbull IC; Kohlbrenner E; Liang L; Zsebo K; Humbert M; Hulot JS; Kawase Y; Hajjar RJ; Leopold JA
Circulation; 2013 Jul; 128(5):512-23. PubMed ID: 23804254
[TBL] [Abstract][Full Text] [Related]
40. Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension.
Masson B; Saint-Martin Willer A; Dutheil M; Penalva L; Le Ribeuz H; El Jekmek K; Ruchon Y; Cohen-Kaminsky S; Sabourin J; Humbert M; Mercier O; Montani D; Capuano V; Antigny F
Am J Physiol Lung Cell Mol Physiol; 2023 Aug; 325(2):L246-L261. PubMed ID: 37366608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
